Top

Published in:

01-01-2009 | Erratum

An FDA Approved Neurokinin-1 Receptor Antagonist is Effective in Reducing Intraabdominal Adhesions when Administered Intraperitoneally, But Not Orally

Authors: Rizal Lim, Jonathan M. Morrill, Scott G. Prushik, Karen L. Reed, Adam C. Gower, Susan E. Leeman, Arthur F. Stucchi, James M. Becker

Published in: Journal of Gastrointestinal Surgery | Issue 1/2009

Excerpt

R Lim, J Morrill, S G Prushik, K L Reed, A C Gower, S E Leeman, A F Stucchi, J M Becker (2008) An FDA Approved Neurokinin-1 Receptor Antagonist is Effective in Reducing Intraabdominal Adhesions when Administered Intraperitoneally, But Not Orally. Journal of Gastrointestinal Surgery 12:1754–1761. …

Title: An FDA Approved Neurokinin-1 Receptor Antagonist is Effective in Reducing Intraabdominal Adhesions when Administered Intraperitoneally, But Not Orally
Authors: Rizal Lim
Jonathan M. Morrill
Scott G. Prushik
Karen L. Reed
Adam C. Gower
Susan E. Leeman
Arthur F. Stucchi
James M. Becker
Publication date: 01-01-2009
Publisher: Springer-Verlag
Published in: Journal of Gastrointestinal Surgery / Issue 1/2009
Print ISSN: 1091-255X
Electronic ISSN: 1873-4626
DOI: https://doi.org/10.1007/s11605-008-0767-5

Keynote webinar | Spotlight on medication adherence

Springer Medicine

An FDA Approved Neurokinin-1 Receptor Antagonist is Effective in Reducing Intraabdominal Adhesions when Administered Intraperitoneally, But Not Orally

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 1/2009

Safety in the OR: Who’s in and Who’s out?

Aviation

Dendritic Cells in Barrett’s Esophagus and Esophageal Adenocarcinoma

Laparoscopic Fundoplication in Patients with a Hypertensive Lower Esophageal Sphincter

Death after Bowel Resection: Patient Disease, Not Surgeon Error

Laparoscopic Right Hepatectomy with Selective Vascular Exclusion